American States Water is a holding company. The company is the parent company of Golden State Water Company (GSWC) and American States Utility Services, Inc. (ASUS). The company segments are: water, electric and contracted services. Within the segments, the company has two principal business units: water and electric service utility operations conducted through GSWC, and contracted services conducted through ASUS and its subsidiaries. GSWC is engaged in the purchase, production, distribution and sale of water as well as distributes electricity in California. ASUS, through its subsidiaries has contracted with United States government to provide water and/or wastewater services at various military installations.

AMN Healthcare Services provides talent solutions for the healthcare sector. The company's talent solutions provides management, staffing, recruitment, technology, analytics, and related services to manage healthcare workforce needs. The company provides its healthcare personnel, from nurses, doctors, and allied health personnel to healthcare leaders and executives. The company's workforce solutions and staffing services include: travel nurse staffing; rapid response nurse staffing and labor disruption services; local, or per diem, staffing; locum tenens staffing; allied staffing; physician permanent placement services; interim leadership staffing and executive search services; and recruitment process outsourcing.

BioCryst Pharmaceuticals is a biotechnology company that discovers oral, small-molecule medicines. The company focuses on oral treatments for rare diseases in which unmet medical needs exist and an enzyme plays the main role in the biological pathway of the disease. The company's drug/drug candidates include: Berotralstat (BCX7353), an oral serine protease inhibitor targeting kallikrein that is being developed as a once-daily oral therapy for the prevention of Hereditary Angioedema; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; and BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive.

Cal-Maine Foods is a producer and marketer of shell eggs. The company has one operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs. The company sells most of its shell eggs in the southwestern, southeastern, mid-western and mid-Atlantic regions of the U.S. through its distribution network to a group of customers, including national and regional grocery store chains, club stores, foodservice distributors and egg product consumers. The company markets cage-free eggs under its trademarked Farmhouse? brand and distributes them across the southeast and southwest regions of the U.S. The company markets organic, cage-free, vegetarian, and omega-3 eggs under its 4-Grain? brand.

Comcast is a media and technology company. The company's segments are: Cable Communications, which provides internet, video, voice, and security and automation services in the United States individually and as bundled services at a discounted rate over its cable distribution system to residential and business customers; NBCUniversal, which includes a portfolio of national cable networks that provide a variety of entertainment, news and information, and sports content, regional sports and news networks, international cable networks, and cable television studio production operations; and Sky, which owns a portfolio of pay television channels that provide entertainment, news, sports and movies.

CPI Card Group is a holding company. Through its subsidiaries, the company is a provider of Financial Payment Card solutions. The company defines Financial Payment Cards as credit, debit and Prepaid Debit Cards issued on the networks of the Payment Card Brands and Interac. The company defines Prepaid Debit Cards as debit cards issued on the networks of the Payment Card Brands. The company's business consists of the following reportable segments: U.S. Debit and Credit, which primarily produces Financial Payment Cards and provides integrated card services to card-issuing banks in the U.S.; and U.S. Prepaid Debit, which primarily provides integrated card services to Prepaid Debit Card issuers in the U.S.

Eastman Chemical is a global advanced materials and specialty additives company. The company's segments are: Additives and Functional Products, which manufactures chemicals for products in the transportation, consumables, building and construction, and other markets; Advanced Materials, which produces and markets polymers, films, and plastics in transportation, consumables, building and construction, durable goods, and health and wellness markets; Chemical Intermediates, which utilizes integration from the cellulose and acetyl, olefins, and alkylamines streams; and Fibers, which manufactures and sells Estron? acetate tow and Estrobond? triacetin plasticizers for use in filtration media.

Editas Medicine is a clinical stage genome editing company focused on developing genomic medicines to treat a range of serious diseases. The company has developed a proprietary genome editing platform based on clustered, regularly interspaced, short palindromic repeats (CRISPR) technology. The company is developing both in vivo CRISPR medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body, and engineered cell medicines, in which cells are edited with the company's technology and then administered to the patient. In ocular diseases, the company's program is designed to address a specific genetic form of retinal degeneration called Leber congenital amaurosis 10.

Enphase Energy is a global energy technology company. The company designs, develops, manufactures and sells home energy solutions that connect energy generation, energy storage and control and communications management on one platform. The company's semiconductor-based microinverter converts energy at the individual solar module level and, combines with its proprietary networking and software technologies to provide energy monitoring and control. The Enphase Home Energy Solution with IQ consists of four primary components: Enphase microinverters, the AC Battery?, an Envoy gateway, and Enlighten cloud-based software.

F5 Networks is a provider of multi-cloud application services, which enable its customers to develop, deploy, operate, secure, and govern applications in any architecture, from on-premises to the public cloud. The company's application services are available as cloud-based, software-as-a-service, and software-only solutions supported for multi-cloud environments. In connection with its solutions, the company provides a range of services, including consulting, training, installation, maintenance, and other technical support services. The company's products and solutions include hardware platforms, software and software-as-a-service platforms, cloud-based managed services, and service provider solutions.

FutureFuel, through its subsidiary, FutureFuel Chemical Company, manufactures various chemical products, bio-based products comprised of biofuels, and bio-based specialty chemical products. The company has two reporting segments: chemicals and biofuels. The company's chemicals segment manufactures chemical products that are sold to third party customers, and comprises two components: custom manufacturing (manufacturing chemicals for certain customers) and performance chemicals (multi-customer specialty chemicals). The company's biofuels segment primarily produces and sells biodiesel to its customers. In addition, the company sells petrodiesel in blends with its biodiesel and, from time to time, with no biodiesel added.

Huntsman is a manufacturer of organic chemical products. The company's products are used in a range of applications, including those in the adhesives, aerospace, automotive, construction products, personal care and hygiene, durable and non-durable consumer products, digital inks, electronics, insulation, medical, packaging, coatings and construction, power generation, refining, synthetic fiber, textile chemicals and dyes industries. The company's primary product lines include methyl diphenyl diisocyanate, amines, maleic anhydride, epoxy-based polymer formulations, textile chemicals and dyes. The company's segments are: Polyurethanes, Performance Products, Advanced Materials and Textile Effects.

John Wiley & Sons is a global research and learning company. Co. has three segments: Research segment, which provides scientific, technical, medical, and scholarly journals, as well as related content and services to libraries and individual researchers, among others; Publishing, which provides scientific, professional, and education books and related content in print and digital formats, test preparation services and course workflow tools, to libraries, corporations, students, professionals, and researchers; and Solutions, which provides online program management services for higher education institutions and learning, development, and assessment services for businesses and professionals.

Keurig Dr Pepper is a beverage company with a portfolio of flavored (non-cola) carbonated soft drinks (CSDs), non-carbonated beverages, and is a producer of single serve brewing systems. The company's Coffee Systems segment develops and sells a variety of Keurig brewers, brewer accessories and other coffee-related equipment. The company's Packaged Beverages segment manufactures and distributes packaged beverages of its brands. The company's Beverage Concentrates segment manufactures and sells beverage concentrates. The company's Latin America Beverages segment participates mainly in the carbonated mineral water, flavored CSD, bottled water and vegetable juice categories.

Kura Oncology is a clinical-stage biopharmaceutical company engaged in developing medicines for the treatment of cancer. The company's key product candidate, tipifarnib, is a selective and orally bioavailable inhibitor of farnesyl transferase. The company's second product candidate is KO-947, a selective small molecule inhibitor of extracellular signal related kinase, which the company is developing as a potential treatment for patients with tumors that have dysregulated activity due to mutations or other mechanisms in the mitogen-activated protein kinase pathway. The company's third product candidate is KO-539, a selective small molecule inhibitor of the menin-mixed lineage leukemia, protein-protein interaction.

Marcus is engaged primarily in two business segments: movie theatres and hotels and resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio, Arkansas, Colorado, Georgia, Kentucky, Louisiana, New York, Pennsylvania, Texas and Virginia, a family entertainment center in Wisconsin and a retail center in Missouri. The hotels and resorts segment owns and operates full service hotels and resorts in Wisconsin, Illinois, Oklahoma and Nebraska and manages full service hotels, resorts and other properties in Wisconsin, Illinois, Minnesota, Texas, Nevada, California and Nebraska.

MarketAxess Holdings operates an electronic trading platform that enables fixed-income market participants to trade corporate bonds and other types of fixed-income instruments using its patented technology. Through its Open Trading? protocols, the company executes trades in certain bond between and among institutional investor and broker-dealer clients. The company also provides trading-related products and services, including: Composite+ pricing and other market data products to assist clients with trading decisions; auto-execution and other execution services for clients requiring specialized workflow solutions; connectivity solutions that facilitate straight-through processing; and technology services.

Miller Industries is a Manufacturer of Towing and Recovery Equipment?. The company manufactures the bodies of wreckers and car carriers, which are installed on truck chassis manufactured by third parties. The company purchases the truck chassis for integration with its towing and recovery equipment and resale to its customers. The company's products are sold through independent distributors that serve various states, Canada and Mexico, and other markets including Europe, the Pacific Rim, the Middle East, South America and Africa, and through prime contractors to governmental entities. The company also manufactures vehicle transport trailers. In addition, the company's independent distributors provide them with parts and service.

PRA Group is a financial and business services company with operations in the Americas, Europe, and Australia. The company's business is the purchase, collection and management of portfolios of nonperforming loans. The company purchases portfolios of nonperforming loans in two categories: Core, which focuses on purchasing and collecting nonperforming loans, which it purchased since either the credit grantor and/or other third-party collection agencies have been unsuccessful in collecting the full balance owed; and Insolvency, which consists of purchasing and collecting on nonperforming loan accounts where the customer is involved in a bankruptcy proceeding or the equivalent in some European countries.

Procter & Gamble provides consumer packaged goods. The company's products are sold primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, baby stores, beauty stores, other stores and pharmacies. The company has five reportable segments: Beauty, which includes hair care, and skin and personal care products; Grooming, which includes shave care products; Health Care, which includes oral care and personal health care products; Fabric and Home Care, which includes fabric care and home care products; and Baby, Feminine and Family Care, which includes baby care, feminine care and family care products.

Rocket Pharmaceuticals is a clinical-stage, multi-platform biotechnology company focused on the development of gene therapies for rare and devastating pediatric diseases. The company has the following inical-stage ex vivo lentiviral vector programs enrolling patients in the U.S. and European Union for Fanconi Anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, Leukocyte Adhesion Deficiency-I, a genetic disorder that causes the immune system to malfunction and Pyruvate Kinase Deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

T-Mobile US provides mobile communications services, including voice, messaging and data, under its brands, T-Mobile and Metro? by T-Mobile, in the United States, Puerto Rico and the United States Virgin Islands. The company provides mobile communications services using its 4G Long-Term Evolution network and its 5G technology network. The company also provides various wireless devices, including handsets, tablets and other mobile communication devices, and accessories for sale, as well as financing through Equipment Installment Plans and leasing through JUMP! On Demand?. The company provides reinsurance for handset insurance policies and extended warranty contracts offered to its mobile communications customers.

Tradeweb Markets is a leader in building and operating electronic marketplaces for its global network of clients across the financial ecosystem. The company's network is comprised of clients across the institutional, wholesale and retail client sectors, including many of the large global asset managers, hedge funds, insurance companies, central banks, banks and dealers, proprietary trading firms and retail brokerage and financial advisory firms, as well as regional dealers. The company's marketplaces facilitate trading across a range of asset classes, including rates, credit, money markets and equities. The company is a global company serving clients in 62 countries with offices in North America, Europe and Asia.

Viking Therapeutics is a biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. The company's main clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta in development for patients with non-alcoholic fatty liver disease and elevated low-density lipoprotein cholesterol. The company's second clinical program's primary drug candidate, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in development for patients recovering from non-elective hip fracture surgery. The company is also developing VK0214 for X-linked adrenoleukodystrophy.